Analyst Activity – JPMorgan Chase Initiates Coverage On NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX) With a Neutral

Analyst Ratings For NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX)

Story continues below

Today, JPMorgan Chase initiated coverage on NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX) with a Neutral with a price target of $18.00.

Some recent analyst ratings include

  • 5/18/2018-JPMorgan Chase initiated coverage with a Neutral rating.


    Recent Trading Activity for NYSE:AMRX – Amneal Pharmaceuticals (NYSE:AMRX)
    Shares of NYSE:AMRX – Amneal Pharmaceuticals closed the previous trading session at 17.74 up +0.95 5.66% with 16.469999313354492 shares trading hands.

    An ad to help with our costs